Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.


  • People with higher 'intellectual arrogance' get better grades

  • Immune gene prevents Parkinson's disease, dementia

  • Dying at home leads to more peace, less grief, but requires wider support

  • Math story time at home bolsters achievement in school

  • Seeing in a new light

  • Smoking, heavy alcohol use are associated with epigenetic signs of aging

  • Opposites don't attract when learning how to use a prosthesis

  • Scientists build a digital piece of a rat's brain

  • Machines have nothing on mom when it comes to listening

  • New clues about how humans become tool users